BULLETIN V2026-2817
THERALASE TECHNOLOGIES INC. ("TLT") ("TLT.WT")
BULLETIN TYPE: Private Placement- Brokered, Additional Listing-Warrants
BULLETIN DATE: September 4, 2026
TSX Venture Tier 2 Company
Financing Type: Brokered Private Placement (LIFE Offering)
Gross Proceeds: $3,555,000
Offering: 14,812,500 Units. Each Unit comprised of 1 Listed Share and 1 Warrant.
Offering Price: $0.24 per Unit
Warrant Exercise Terms: $0.32 per Listed Share until May 20, 2031
Commissions in Securities: The brokers received 903,723 Broker warrants for their services rendered.
Broker Warrants:
#Broker Warrants
(Aggregate # of Brokers: 1) 903,723
Broker Warrant Terms: Each Broker Warrant is non-transferable and exercisable into one Unit at $0.24 until May 20, 2031.
Additional Listing of Warrants ("TLT.WT"):
Further to the Exchange bulletins dated June 5, 2026, and September 4, 2026, up to 15,716,223 additional listed Warrants ("TLT.WT") (CUSIP: 88337V142) of the Company have been authorized for issuance pursuant to a supplemental warrant indenture dated August 24, 2026.
Revised Capitalization: Up to 36,115,273 Warrants, authorized by a Warrant Indenture dated May 20, 2026, and supplemented by a first Supplemental Warrant Indenture dated August 24, 2026, of which 33,979,167 Warrants are issued and outstanding.
Disclosure: Refer to the offering document dated August 10, 2026, and the company's news release(s) dated August 10, 2026 and August 24, 2026.
_______________________________________
|
|
